Page 122 - MemoriaCIBER2019-ENG

122
CIBER Annual report 2019
• Guide 1 - Su enfermedad tiene que ver con el trabajo (Your illness has to do with your job) (https://www.upf.edu/documents/3192961/3207869/2018_11_29_GUIA+1+PROYECTO+CEPS.pdf/ b696d3a3-ed88-a22b-2424-53bfbf43d86b)
• Guide 2 - Hacer visible la enfermedad profesional (Making occupational disease visible) (https://www.upf.edu/documents/3192961/3207869/2019_03_01_GUIA+2+CEPS.pdf/c9344130-3ab8- 8418-99d8-883f3b5cc77c)
Participation in the VI Meeting of the Expert Network on Working Conditions, Employment and Health Surveys (ECo- TES Network) held on June 26-27, 2019 in Montevideo (Uruguay).
The Network has a website in Spanish, English and Portuguese http://www.ecotes.una.ac.cr/ that will help further their objectives and which has been designed and financed financially by the Group.
Group led by Antoni Serrano Blanco (PI): Dr. Maria Rubio Valera obtained a Miguel Servet contract awarded by the ISCIII. The group has obtained two FIS projects focused on the study of adherence to antipsychotics and their derived costs and on the study of non-initiation of drugs in the pediatric population with mixed methodology.
Dr. Maria Iglesias González defended her doctoral thesis entitled “Effectiveness and feasibility of watchful waiting for the management of major depression in primary care” at the Universitat de Barcelona and obtained the qualification of cum laude.
P7. Clinical epidemiology
Coordinator: José Ignacio Pijoán Zubizarreta
In 2019, several new financed competitive projects were obtained in the AES 2019 call: i) “Analysis of the prognostic value of biomarkers in sepsis. Series of Systematic Reviews and GRADE recommendations for clinical practice” with the participation of the programme groups of Javier Zamora (leader), José Ignacio Emparanza Knörr and Xavier Bon- fill Cosp; ii) “Analysis and improvement of the adequacy of the chemotherapy prescription at the end of life” of the groups led by X. Bonfill and I. Emparanza, along with other groups.
We have continued making progress in carrying out actions to transfer the knowledge available in the scientific lite- rature to clinical practice through the constitution of new MAPAC commissions to improve the adequacy of care in Spanish hospitals and the consolidation of existing ones. Some of the cooperative projects derived from the MAPAC initiative have yielded results published this year, such as: “Opiniones, barreras y facilitadores de los profesionales de la salud hacia las prácticas clínicas de poco valor en el ámbito hospitalario” (“Opinions, barriers and facilitators of health professionals towards clinical practices of little value in the hospital setting”), published in Gaceta Sanitaria by Ignacio Ferreira’s group; or, in the field of rapid reviews: “Rapid reviews of medical tests used many similar methods to systematic reviews but key items were rarely reported: a scoping review”, published in the Journal of Clinical Epi- demiology by the groups led by X. Bonfill, I. Emparanza and J. Zamora.
The DIANASALUD platform has been updated with 178 new recommendations on low-value clinical practices.
Several Programme groups have led or participated in the preparation of Cochrane Reviews published in 2019, highlighting, for example: “Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults” and “Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children”.
We have obtained the first results of the analysis of large population-based clinical and administrative databases for the study of therapeutic adherence and health results: “Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Cata- lonia (Spain)”, published in BMJ Open by the groups led by I. Ferreira and I. Emparanza.
Other noteworthy milestones of the Programme are: obtaining the IV SHAM Award in recognition of the best pro- jects in patient safety, quality of care, prevention and management of health risks carried out in Spain for the study “Evaluation of an evidence-based intervention to reduce central vascular catheter- associated bacteremia in very low birth weight infants. INBERBAC-Neo Project” by the groups of José Ignacio Emparanza Knörr (leader), Ignacio Ferreira González, Javier Zamora and Xavier Bonfill Cosp and the recognition of the Cochrane Centre of the community of Madrid (Javier Zamora’s group) as a Cochrane associate center.